JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB – Research Report), Perspective ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has ...
Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, ...
Fintel reports that on March 3, 2025, B of A Securities downgraded their outlook for Zai Lab Limited - Depositary Receipt () ...
Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Zai Lab Limited - Depositary Receipt () (NasdaqGM:ZLAB ...
Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s ...
Scotiabank initiated coverage of Zai Lab (ZLAB) with an Outperform rating and $55 price target The firm says that although geopolitical risk ...
Shares of Zai Lab Limited Unsponsored ADR (ZLAB) have gained 15.9% over the past four weeks to close the last trading session at $31.73, but there could still be a solid upside left in the stock if ...
Scotiabank initiated coverage on shares of Zai Lab (NASDAQ:ZLAB – Free Report) in a research note issued to investors on Friday morning, Ratings reports. The firm issued a sector outperform rating and ...